Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-17-008374
Filing Date
2017-02-21
Accepted
2017-02-21 17:03:26
Documents
2
Period of Report
2017-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 7143
2 poa_mariacantor.htm EX-24 8219
  Complete submission text file 0001140361-17-008374.txt   16725
Mailing Address C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Cantor Maria E (Reporting) CIK: 0001542768 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36294 | Film No.: 17625847

Mailing Address MEIBERGDREFF 61 AMSTERDAM P7 1005 BA
Business Address MEIBERGDREFF 61 AMSTERDAM P7 1005 BA 31-20-5667394
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations